4.130USD-3.95%Mkt Cap: 388.13M USDP/E: —Last update: 2026-06-01
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an ora…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap388.13M USD
Enterprise Value250.05M USD
Revenue (TTM)9.01M USD
Gross Profit29.36M USD
Net Income (TTM)-79.20M USD
Revenue/Share0.1250 USD
Last Price4.130 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees45
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.79
PEG—
EV/EBITDA-2.79
EV/Revenue27.74
P/S45.10
P/B2.41
EPS (TTM)-2.07
EPS (Forward)-0.90
52W Range
1.35080% of range4.830
52W High4.830 USD
52W Low1.350 USD
Profitability
Gross Margin83.60%
Oper. Margin-748.49%
EBITDA Margin0.00%
Profit Margin-225.55%
ROE-42.51%
ROA-27.27%
Growth
Revenue Growth-90.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-85.62M USD
CapEx (TTM)3.00M USD
FCF Margin-612.07%
FCF Yield-14.21%
Net Debt-156.47M USD
Net Debt/EBITDA1.74
Balance Sheet
Debt/Equity0.41
Current Ratio10.18
Quick Ratio9.88
Book Value/Sh1.786 USD
Cash/Share2.478 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 14, 2019
Splits
Last Split1:30
Split DateApr 28, 2025
Analyst Consensus
Rating—
Target (Mean)11.67 USD
Target Range10.00 USD – 13.00 USD
# Analysts3
Ownership
Shares Out.94.32M
Float57.41M
Insiders0.61%
Institutions99.60%
Short Interest
Short Ratio8.0d
Short % Float3.11%
Short % Out.3.10%
Shares Short2.92M
Short (prev mo.)3.14M
Technical
SMA 504.133 (-0.1%)
SMA 2003.728 (+10.8%)
Beta0.32
S&P 52W Chg27.70%
Avg Vol (30d)353.28K
Avg Vol (10d)358.51K
Technical Indicators
RSI (14)57.0
MACD-0.0160
MACD Signal-0.0334
MACD Hist.+0.0175
BB Upper4.594 USD
BB Middle4.117 USD
BB Lower3.640 USD
BB Width23.16%
ATR (14)0.2411 USD
Vol Ratio (20d)1.97x